Roche Diabetes Care India unveils ACCU-FINE pen needles for virtually painless insulin delivery
The ACCU-FINE needles are available in packs of 100 in three variants including a 33G 4mm variant, which is a first in India.
Advertisement
Mumbai: Roche Diabetes Care India (RDC India) today announced the launch of ACCU-FINE, pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes.
This latest innovation from Roche Diabetes Care, makers of ACCU-CHEK, aims to make the process of insulin delivery easier thereby leading to better diabetes management for people with diabetes.
The ACCU-FINE needles are available in packs of 100 in three variants including a 33G 4mm variant, which is a first in India. Based on deep customer insights, the ACCU-FINE Pen Needles are specially designed with three key features to make them gentle in use. First, the needle has a special cut at the tip to ensure gentle insertion; second, the needle has a thin wall to enable rapid insulin flow; and third, the needle has a special coating that allows it to be inserted into the skin easily. The needles come with a sealed sterile protective cap and an additional protective cap for double protection.
Speaking about this launch, Omar Sherief, Cluster Head – India Middle East and Africa, RDC said, "An important part of successful diabetes management is regular and timely insulin delivery. The process of injecting is sometimes unpleasant for people with diabetes, causing fear.
This often leads to insulin initiation delay which is closely associated with poor glycemic control and further clinical complications. In keeping with our commitment to #PutPatientsFirst, we believe that our ACCU- FINE Pen Needles will make the insulin initiation experience easier & virtually painless for people with diabetes. With this initiative we are one step closer to helping people with diabetes manage their condition better."
The product is already available for purchase in pharmacies across the Indian market.
Read also: Roche Diabetes Care India, Fitterfly Healthtech ink pact for diabetes management program
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.